Bonus Presentations
DAY 1
FRIDAY,
SEPTEMBER 18
9:45 am
—
10:45 am
Non-CME/CE Bonus Presentation
In ESR1-mutated, ER+/HER2- mBC following progression on ET ORSERDU® (elacestrant): Powerful efficacy in EMERALD@, now with published real-world evidence 1-3
Speaker: Adam Brufsky, MD, PHD, FACP
Sponsored by Menarini Stemline
DAY 1
FRIDAY,
SEPTEMBER 6
No items found.
Disclaimer: Bonus Presentations are independently organized and not an official part of the Perspectives in Breast Cancer Care 2026 program. All presentations are Non-CME unless otherwise noted.